Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases

被引:1
|
作者
Issa, Shaza [1 ]
Fayoud, Haidar [1 ]
Shaimardanova, Alisa [2 ]
Sufianov, Albert [3 ,4 ]
Sufianova, Galina [5 ]
Solovyeva, Valeriya [2 ]
Rizvanov, Albert [2 ,6 ]
机构
[1] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia
[2] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan 420008, Russia
[3] Sechenov First Moscow State Med Univ, Sechenov Univ, Dept Neurosurg, Minist Hlth Russian Federat, Moscow 119991, Russia
[4] Peoples Friendship Univ Russia RUDN, Res & Educ Inst Neurosurg, Moscow 117198, Russia
[5] Tyumen State Med Univ, Dept Pharmacol, Tyumen 625023, Russia
[6] Tatarstan Acad Sci, Div Med & Biol Sci, Kazan 420111, Russia
关键词
growth factors; hereditary neurodegenerative diseases; gene therapy; BDNF; GDNF; IGF-1; VEGF; NGF; FGF-2; CNTF; TGF-beta; 1; HGF; CILIARY NEUROTROPHIC FACTOR; MESENCHYMAL STEM-CELLS; FACTOR SCATTER FACTOR; FACTOR GENE-THERAPY; INSULIN-LIKE; PARKINSONS-DISEASE; RAT MODEL; HUNTINGTONS-DISEASE; DOPAMINERGIC-NEURONS; FACTOR-I;
D O I
10.3390/biomedicines12081906
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary neurodegenerative diseases (hNDDs) such as Alzheimer's, Parkinson's, Huntington's disease, and others are primarily characterized by their progressive nature, severely compromising both the cognitive and motor abilities of patients. The underlying genetic component in hNDDs contributes to disease risk, creating a complex genetic landscape. Considering the fact that growth factors play crucial roles in regulating cellular processes, such as proliferation, differentiation, and survival, they could have therapeutic potential for hNDDs, provided appropriate dosing and safe delivery approaches are ensured. This article presents a detailed overview of growth factors, and explores their therapeutic potential in treating hNDDs, emphasizing their roles in neuronal survival, growth, and synaptic plasticity. However, challenges such as proper dosing, delivery methods, and patient variability can hinder their clinical application.
引用
收藏
页数:33
相关论文
共 50 条
  • [41] Metformin - a Future Therapy for Neurodegenerative Diseases
    Markowicz-Piasecka, Magdalena
    Sikora, Joanna
    Szydlowska, Aleksandra
    Skupien, Agata
    Mikiciuk-Olasik, Elzbieta
    Huttunen, Kristiina M.
    PHARMACEUTICAL RESEARCH, 2017, 34 (12) : 2614 - 2627
  • [42] New hope for therapy in neurodegenerative diseases
    Costa, Maria do Carmo
    Paulson, Henry L.
    CELL RESEARCH, 2013, 23 (10) : 1159 - 1160
  • [43] New hope for therapy in neurodegenerative diseases
    Maria do Carmo Costa
    Henry L Paulson
    Cell Research, 2013, 23 : 1159 - 1160
  • [44] Biomedical Application of Phosphoproteomics in Neurodegenerative Diseases
    Bahk, Young Yill
    Mohamed, Bari
    Kim, Young Jun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2013, 23 (03) : 279 - 288
  • [45] Hypothesis for the cause and therapy of neurodegenerative diseases
    Serwer, Philip
    MEDICAL HYPOTHESES, 2018, 110 : 60 - 63
  • [46] Application of Precision Medicine in Neurodegenerative Diseases
    Strafella, Claudia
    Caputo, Valerio
    Galota, Maria R.
    Zampatti, Stefania
    Marella, Gianluca
    Mauriello, Silvestro
    Cascella, Raffaella
    Giardina, Emiliano
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [47] Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives
    El Ouaamari, Yousra
    van den Bos, Jasper
    Willekens, Barbara
    Cools, Nathalie
    Wens, Inez
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [48] Novel neurotrophic factors for the treatment of neurodegenerative diseases
    Saarma, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S128 - S129
  • [49] The growing evidence of neurodegenerative diseases risk factors
    Ruiz-Garcia, Ramiro
    REVISTA MEXICANA DE NEUROCIENCIA, 2023, 24 (01): : 1 - 2
  • [50] Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases
    Yossef S. Levy
    Yossi Gilgun-Sherki
    Eldad Melamed
    Daniel Offen
    BioDrugs, 2005, 19 : 97 - 127